Traded Nov 9 – Nov 11, 2026 · largest single transaction ~$787K
Lately at Pampa Energy: the stock is down 22% in 30 days; insiders made 24 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Checked for new insider filings 3 h ago
Guides: What is an SEC Form 4 · the transaction codes · who has to file · 10b5-1 plans
Worth a look: purchases of $10K+ and sales of $250K+ not reported under a pre-arranged trading plan.
Traded Nov 9 – Nov 11, 2026 · largest single transaction ~$787K
Lately at Pampa Energy: the stock is down 22% in 30 days; insiders made 24 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Nov 9, 2026~$787K · 12K sh @ $64.60
DetailsOfficial recordNov 11, 2026~$489K · 7,667 sh @ $63.72
DetailsOfficial recordInsider buying
First insider buy since Mar 2025Traded Nov 12 · filed the same day
Since the trade −16.6% · S&P 500 −8.9% · to Nov 20
Bought 22% below the 52-week high, RSI 46, 62% above its 200-day average
A major shareholder of Abcellera Biologics paid $699K out of pocket for Abcellera Biologics shares. 1 other person at Abcellera Biologics bought some too, in the same month. It was the first purchase in 20 months.
Lately at Abcellera Biologics: it reported its results on Nov 9; the stock is down 21% in 30 days; insiders made 2 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
First insider buy since Dec 2022Traded Nov 11 · filed 1 day later
Since the trade −5.3% · S&P 500 −9.2% · to Nov 20
Bought 45% below the 52-week high, RSI 37, 21% under its 200-day average, 25 points behind the S&P 500 over 3 months
The CEO of Target Hospitality paid $313K out of pocket for Target Hospitality shares. 2 other people at Target Hospitality bought some too, in the same month.
Lately at Target Hospitality: the stock rose 15% in one session on Nov 11 with press coverage; it reported its results on Nov 9; the stock is down 29% in 30 days.
Insider buying
Open-market purchases, traded Nov 11, 2026. Each amount is that person's own.
Lately at Larimar Therapeutics: the stock fell 16% in one session on Nov 5 with press coverage; it reported its results on Nov 16; the stock is up 30% in 30 days.
Traded Nov 9 – Nov 10, 2026 · largest single transaction ~$1.71M
Lately at Claritev: the stock rose 19% in one session on Nov 10 with press coverage; it changed a top executive or board member on Oct 15; the stock is down 21% in 30 days.
Nov 10, 2026~$1.71M · 66K sh @ $26.14
DetailsOfficial recordNov 9, 2026~$1.22M · 50K sh @ $24.42
DetailsOfficial recordInsider buying
Their first buy on recordTraded Nov 11 · filed 1 day later
Since the trade −19.6% · S&P 500 −9.2% · to Nov 20
Bought 46% below the 52-week high, RSI 45, 18% under its 200-day average, 21 points behind the S&P 500 over 3 months
A Draftkings director paid $99K out of pocket for Draftkings shares. 2 other people at Draftkings bought some too, in the same month. Shares held went up 28% with this purchase.
Lately at Draftkings: the stock fell 21% in one session on Nov 6 around a company release; it reported its results on Nov 6; the stock is down 23% in 30 days.
Insider buying
First insider buy since Jun 2024Traded Nov 10 · filed 2 days later
Since the trade −4.0% · S&P 500 −8.0% · to Nov 20
Bought within 2% of the 52-week high, RSI 68, 24% above its 200-day average, 23 points ahead of the S&P 500 over 3 months
The CEO of Eagle Bancorp paid $150K out of pocket for Eagle Bancorp shares. 1 other person at Eagle Bancorp bought some too, in the same month. It was the first purchase in over a year.
Lately at Eagle Bancorp Inc: it reported its results on Oct 21; the stock is up 14% in 30 days; insiders made 2 purchases ($10K+) and 2 large sales ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Nov 9 · filed 3 days later
Since the trade −6.9% · S&P 500 −8.3% · to Nov 20
Bought at the 52-week low, RSI 36, 22% under its 200-day average, 20 points behind the S&P 500 over 3 months
A major shareholder of Joint paid $1.57M out of pocket for Joint shares. Shares held went up 13% with this purchase.
Lately at Joint: it reported its results on Nov 5; the stock is down 14% in 30 days; insiders made 6 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Nov 9 · filed 3 days later
Since the trade +14.0% · S&P 500 −8.3% · to Nov 20
Bought within 4% of the 52-week low, RSI 24, 24% under its 200-day average, 32 points behind the S&P 500 over 3 months
A Stevanato Group S.P.A. director paid $274K out of pocket for Stevanato Group S.P.A. shares. 1 other person at Stevanato Group S.P.A. bought some too, in the same month. Shares held went up 74% with this purchase.
Lately at Stevanato Group S.P.A.: the stock rose 10% in one session on Nov 13 with press coverage; the stock is down 17% in 30 days; insiders made 2 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Nov 9 · filed 3 days later
Since the trade −1.3% · S&P 500 −8.3% · to Nov 20
Bought at the 52-week low, RSI 17, 32% under its 200-day average, 25 points behind the S&P 500 over 3 months
An Amdocs director paid $101K out of pocket for Amdocs shares. 7 other people at Amdocs bought some too, in the same month. Shares held went up 10% with this purchase.
Lately at Amdocs: the stock fell 30% in one session on Nov 4 with press coverage; the stock is down 33% in 30 days; insiders made 7 purchases ($10K+) and 2 large sales ($250K+, not pre-arranged) in 90 days.
Insider buying
First insider buy since Oct 2024Traded Nov 9 · filed 3 days later
Since the trade −8.2% · S&P 500 −8.3% · to Nov 20
Bought within 1% of the 52-week low, RSI 23, 44% under its 200-day average, 25 points behind the S&P 500 over 3 months
An Alnylam Pharmaceuticals director paid $300K out of pocket for Alnylam Pharmaceuticals shares. 1 other person at Alnylam Pharmaceuticals bought some too, in the same month. It was the first purchase in over a year.
Lately at Alnylam Pharmaceuticals: the stock fell 25% in one session on Oct 29 around a company release; it changed a top executive or board member on Nov 5; the stock is down 36% in 30 days.
Insider buying
Traded Nov 6 · filed 6 days later
Since the trade −17.0% · S&P 500 −6.2% · to Nov 20
Bought within 1% of the 52-week low, RSI 20, 39% under its 200-day average, 40 points behind the S&P 500 over 3 months
Ferroglobe's Gabriel Girardeau, SEE REMARKS paid $41K out of pocket for Ferroglobe shares. 4 other people at Ferroglobe bought some too, in the same month. Shares held went up 28% with this purchase.
Lately at Ferroglobe: the stock fell 14% in one session on Nov 5 with press coverage; the stock is down 49% in 30 days; insiders made 5 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
3 insiders in a week, a first since 2020Traded Nov 10 · filed 2 days later
Since the trade −6.9% · S&P 500 −8.0% · to Nov 20
Bought 50% below the 52-week high, RSI 39, 33% under its 200-day average, 30 points behind the S&P 500 over 3 months
MP Materials's Chief Operating Officer paid $617K out of pocket for MP Materials shares. 2 other people at MP Materials bought some too, in the same month.
Lately at MP Materials: it reported its results on Nov 5; the stock is down 14% in 30 days; insiders made 8 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Nov 11 · filed 1 day later
Since the trade −11.0% · S&P 500 −9.2% · to Nov 20
Bought 33% below the 52-week high, RSI 56
The CEO of Runway Growth Finance paid $50K out of pocket for Runway Growth Finance shares. 1 other person at Runway Growth Finance bought some too, in the same month. Shares held went up 107% with this purchase.
Lately at Runway Growth Finance: it reported its results on Nov 5; the stock is down 5% in 30 days; insiders made 4 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Their first buy on recordTraded Nov 10 · filed 2 days later
Since the trade −12.8% · S&P 500 −8.0% · to Nov 20
Bought 50% below the 52-week high, RSI 45, 28% under its 200-day average, 37 points behind the S&P 500 over 3 months
A Coherent director paid $223K out of pocket for Coherent shares. 1 other person at Coherent bought some too, in the same month. It was the first purchase in over a year.
Lately at Coherent Corp.: it reported its results on Nov 4; the stock is down 21% in 30 days; insiders made 2 purchases ($10K+) and 3 large sales ($250K+, not pre-arranged) in 90 days.
Insider buying
First insider buy since Mar 2020Traded Nov 10 · filed 2 days later
Since the trade −5.6% · S&P 500 −8.0% · to Nov 20
The CEO of Hornbeck Offshore Services paid $1M out of pocket for Hornbeck Offshore Services shares.
Lately at Hornbeck Offshore Services: the stock fell 13% in one session on Nov 5 around a company release; it reported its results on Nov 5; the stock is down 26% in 30 days.
Insider buying
4 insiders in a week, a first since 2021Traded Nov 11 · filed 1 day later
Since the trade −3.1% · S&P 500 −9.2% · to Nov 20
Bought 64% below the 52-week high, RSI 43, 42% under its 200-day average, 32 points behind the S&P 500 over 3 months
A Drilling Tools International director paid $24K out of pocket for Drilling Tools International shares. 6 other people at Drilling Tools International bought some too, in the same month. Shares held went up 23% with this purchase.
Lately at Drilling Tools International: it reported its results on Nov 5; the stock is down 14% in 30 days; insiders made 14 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.